trial · primary record
Pasritamig
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2028-03-15 |
| Primary endpoint | Number of Participants With Adverse Events (AEs) by Severity |
| Registry ID | NCT07319871 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:14.131Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07319871
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Pasritamig · compound